Form D · Pharmaceuticals
Canada Cannabis Corp.
Oakville, A6 · CIK 0001607438
Offering snapshot reported May 9, 2014 · SEC filing
- Reported sold
- $5.37M Offering amount: $15M
- Investors reported
- 45 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Mar 4, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 9, 2014 | Initial | $5,370,903 | No comparison | 45 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0 (estimated)
- Finders' fees
- $0 (estimated)
- Form D file number
- 021-217096
Total offering Amount may be increased to $18,000,000 at the discretion of the Company
Source: Form D, filed May 9, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John Carlos Esteireiro | Executive |
| Peter Tuero Strang | Director |
| Benjamin Allan Ward | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
2368 Lakeshore Road West Suite 205
Oakville, A6, L6L 1H5
Oakville, A6, L6L 1H5